Philippe Weigerstorfer - Jan 2, 2025 Form 4 Insider Report for Sonoma Pharmaceuticals, Inc. (SNOA)

Role
Director
Signature
/s/ Amy Trombly as attorney-in-fact
Stock symbol
SNOA
Transactions as of
Jan 2, 2025
Transactions value $
$0
Form type
4
Date filed
1/3/2025, 05:02 PM
Previous filing
Dec 30, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNOA Stock option (right to buy) Award +7.5K +299.88% 10K Jan 2, 2025 Common Stock 7.5K $2.68 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest one third each on 1/2/2026, 1/2/2027 and 1/2/2028, or upon change of control.
F2 The options were awarded and granted to Mr. Weigerstorfer for services performed on the Board of Directors as part of the Company's annual grant of stock options.